VOKANAMET 50/500 TABLET is a combination of Canagliflozin and Metformin, which belongs to the group of medicines called Antidiabetic agents. It is used as an adjunct to diet and exercise to control blood sugar levels and also helps manage heart disease in adults with type II diabetes mellitus when it cannot be controlled by metformin alone or together with other diabetes medicines.
Type II diabetes mellitus is a chronic disease characterized by abnormally high levels of glucose in the blood. It is caused by inadequate production of a hormone called insulin (produced by the pancreas to metabolize glucose) in the body or by inadequate sensitivity of body cells to the actions of insulin.
Before and during management with VOKANAMET 50/500 TABLET, your doctor will check for kidney function by conducting a blood test. VOKANAMET 50/500 TABLET is not recommended for use during pregnancy or in breastfeeding women. Talk to your doctor about whether to stop taking VOKANAMET 50/500 TABLET or to stop breast-feeding.
[GBKEYWORD] is not recommended for use if you have severe breathing difficulties, severe kidney disease, liver disease, a heart attack, or have severe blood circulation problems, such as shock. Consult your doctor before taking this VOKANAMET 50/500 TABLET.
The most common side effects of taking VOKANAMET 50/500 TABLET are low blood glucose levels, severe infection of the urinary tract, vaginal yeast infection, constipation, feeling thirsty, and nausea. Consult your doctor if any of the side effects worsen.
No content available
